Chemomab Therapeutics Ltd.

CMMB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$6,071$9,292$13,519$14,686
Short-Term Investments$8,195$10,492$26,374$45,975
Receivables$263$289$459$179
Inventory$0$0$0-$1,348
Other Curr. Assets$1,511$824$1,384$2,696
Total Curr. Assets$16,040$20,897$41,736$62,688
Property Plant & Equip (Net)$539$695$594$702
Goodwill$0$0$0$0
Intangibles$7$8$0$14
Long-Term Investments$0$0$0$55
Tax Assets$0$0$0$0
Other NC Assets$378$551$733$894
Total NC Assets$924$1,254$1,327$1,665
Other Assets$0$0$0$0
Total Assets$16,964$22,151$43,063$64,353
Liabilities
Payables$666$516$1,688$1,336
Short-Term Debt$230$152$123$212
Tax Payable$0$0$351$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,322$4,170$4,587$1,102
Total Curr. Liab.$3,218$4,838$6,749$2,650
LT Debt$209$316$91$237
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$209$316$91$237
Other Liabilities$0$0$0$0
Cap. Leases$324$392$214$343
Total Liabilities$3,427$5,154$6,840$2,887
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$102,623-$88,678-$63,819-$36,173
AOCI$0$0-$0$0
Other Equity$116,160$105,675$100,042$97,639
Total Equity$13,537$16,997$36,223$61,466
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$16,964$22,151$43,063$64,353
Net Debt-$5,632-$8,824-$13,305-$14,237